Drug eluting Bio-resolvable Scaffold (BRS)
Showing 1 - 25 of >10,000
Critical Limb-Threatening Ischemia, Critical Limb Ischemia, Critical Lower Limb Ischemia Trial (MAGNITUDE BRS)
Not yet recruiting
- Critical Limb-Threatening Ischemia
- +2 more
- MAGNITUDE BRS
- (no location specified)
Oct 4, 2023
Coronary Artery Disease Trial (MeRes 100 Sirolimus-eluting Bioresorbable Vascular Scaffold System (BRS))
Not yet recruiting
- Coronary Artery Disease
- MeRes 100 Sirolimus-eluting Bioresorbable Vascular Scaffold System (BRS)
- (no location specified)
Jun 10, 2022
Chronic Limb-Threatening Ischemia Trial (MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold, Percutaneous Transluminal
Not yet recruiting
- Chronic Limb-Threatening Ischemia
- MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold
- Percutaneous Transluminal Angioplasty (PTA)
- (no location specified)
Oct 9, 2023
Bioresorbable Vascular Scaffold in Routine Clinical Practice
Active, not recruiting
- Arterial Occlusive Diseases
- +3 more
- Bioresorbable Vascular Scaffold
-
Seoul, Songpa-gu, Korea, Republic of
- +13 more
Dec 11, 2022
Critical Limb Ischemia Trial in Saint Helena, Leipzig (MOTIV Sirolimus-Eluting Bioresorbable Scaffold, Percutaneous Transluminal
Recruiting
- Critical Limb Ischemia
- MOTIV Sirolimus-Eluting Bioresorbable Scaffold
- Percutaneous Transluminal Angioplasty (PTA) Device
-
Saint Helena, California
- +1 more
Oct 19, 2022
Coronary Artery Disease, Stable Angina, Coronary Artery Stenosis Trial in Odense (ScoreFlex balloon, Device: standard
Recruiting
- Coronary Artery Disease
- +9 more
- ScoreFlex balloon
- Device: standard non-compliant balloon
-
Odense, DenmarkOdense University Hospital
Nov 30, 2021
Coronary Artery Disease, Atherosclerosis, Coronary, Myocardial Ischemia Trial (DREAMS 3G RMS, Xience DES)
Not yet recruiting
- Coronary Artery Disease
- +5 more
- DREAMS 3G RMS
- Xience DES
- (no location specified)
Sep 12, 2022
Infrapopliteal Lesions, Critical Limb Ischemia Trial in Florence (Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold
Recruiting
- Infrapopliteal Lesions
- Critical Limb Ischemia
- Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan™)
-
Florence, ItalyAzienda Ospedaliero Universitaria Careggi
Jul 31, 2023
Coronary Artery Disease With Myocardial Infarction Trial in Korea, Republic of (routine stress testing, No Routine stress
Completed
- Coronary Artery Disease With Myocardial Infarction
- routine stress testing
- No Routine stress testing
-
Chuncheon, Korea, Republic of
- +10 more
Apr 3, 2022
Coronary Artery Disease Trial in Kunming (Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (IBS), Abbott Vascular
Recruiting
- Coronary Artery Disease
- Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (IBS)
- Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System
-
Kunming, ChinaFuwai Yunnan Cardiovascular Hospital
Mar 16, 2022
Critical Limb Ischemia Trial (Drug Eluting Temporary Spur Stent System, Percutaneous Transluminal Balloon Angioplasty)
Not yet recruiting
- Critical Limb Ischemia
- Drug Eluting Temporary Spur Stent System
- Percutaneous Transluminal Balloon Angioplasty
- (no location specified)
Nov 8, 2023
Coronary Artery Disease Trial in Kunming (Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System)
Recruiting
- Coronary Artery Disease
- Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
-
Kunming, Yunnan, ChinaFuwai Yunnan Cardiovascular Hospital
Mar 16, 2022
IRIS-BVS AMI Registry
Terminated
- Arterial Occlusive Diseases
- +2 more
- Bioresorbable Vascular Scaffold
-
Seoul, Korea, Republic ofAsan Medical Center
Sep 6, 2021
Chronic Coronary Syndrome Trial (Magic Touch drug eluting balloon based strategy, Drug-eluting stent-based strategy)
Not yet recruiting
- Chronic Coronary Syndrome
- Magic Touch drug eluting balloon based strategy
- Drug-eluting stent-based strategy
- (no location specified)
Jan 5, 2023
Coronary Artery Disease Trial in Fribourg (Implantation of everolimus-eluting bioresorbable vascular scaffold stent,
Completed
- Coronary Artery Disease
- Implantation of everolimus-eluting bioresorbable vascular scaffold stent
- +2 more
-
Fribourg, SwitzerlandFribourg Cantonal Hospital
Oct 14, 2021
Critical Limb Ischemia (CLI) Trial in China (Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan™),
Recruiting
- Critical Limb Ischemia (CLI)
- Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan™)
- Percutaneous Transluminal Angioplasty (PTA) Device
-
Beijing, China
- +28 more
Mar 16, 2022
Spinal Fusion Trial in Bologna (Vertebral bone marrow clot)
Active, not recruiting
- Spinal Fusion
- Vertebral bone marrow clot
-
Bologna, BO, ItalyIstituto Ortopedico Rizzoli
Jun 27, 2023
Restenosis Trial in Ostrava (paclitaxel-coated balloon catheter with Iopromide coating, drug eluting stent with everolimus,
Completed
- Restenosis
- paclitaxel-coated balloon catheter with Iopromide coating
- +2 more
-
Ostrava, CzechiaUniversity Hospital
Dec 6, 2022
ACL - Anterior Cruciate Ligament Rupture Trial in Gulf Breeze (Bio ACL, Control)
Active, not recruiting
- ACL - Anterior Cruciate Ligament Rupture
- Bio ACL
- Control
-
Gulf Breeze, FloridaAndrews Institute
Jan 30, 2023
Coronary Restenosis Trial in Ostrava (sirolimus-eluting balloon (SEB) MagicTouch, paclitaxel-eluting balloon (PEB) Sequent
Completed
- Coronary Restenosis
- sirolimus-eluting balloon (SEB) MagicTouch
- paclitaxel-eluting balloon (PEB) Sequent Please
-
Ostrava, CzechiaCardiovascular Department of University Hospital
Dec 6, 2022
Critical Limb Ischemia Trial in Singapore (BVS, Abbott Vascular)
Completed
- Critical Limb Ischemia
- BVS, Abbott Vascular
-
Singapore, SingaporeChangi General Hospital
Oct 6, 2020
In-stent Restenosis Trial (Drug-eluting Coronary Spur Stent System)
Not yet recruiting
- In-stent Restenosis
- Drug-eluting Coronary Spur Stent System
- (no location specified)
Oct 31, 2023
Percutaneous Coronary Intervention, Myocardial Revascularization, Tomography, Optical Coherence Trial in Genk, Leuven, Rotterdam
Recruiting
- Percutaneous Coronary Intervention
- +2 more
- Fantom Encore Bioresorbable scaffold implantation
-
Genk, Belgium
- +2 more
Oct 12, 2020
Coronary Artery Disease, Ischemic Heart Disease Trial in Suwon (Procedure: planed 2-stent strategy, Procedure: provisional
Recruiting
- Coronary Artery Disease
- Ischemic Heart Disease
- Procedure: planed 2-stent strategy
- Procedure: provisional 1-stent plus DEB strategy
-
Suwon, Gyeonggi-do, Korea, Republic ofSt. Vincent's Hospital , the Catholic University
Aug 17, 2023
Myocardial Infarction, Coronary Artery Disease Trial in Odense (OCT guided PCI, Angiography guided PCI)
Active, not recruiting
- Myocardial Infarction
- Coronary Artery Disease
- OCT guided PCI
- Angiography guided PCI
-
Odense, Region Of Southern Denmark, DenmarkOdense University Hospital
Feb 28, 2021